首頁 > 市場調查報告書 > 醫療設備

病患監測體外診斷血糖監測

市場調查報告書

商品編碼

1563125

連續血糖監測系統的全球市場：依產品、應用、最終用戶和地區的預測（~2032年）

Global Continuous Glucose Monitoring Systems Market Research Report Information by Product, By Application, By End User, by Region Forecast till 2032

出版日期: 2024年08月10日 | 出版商:

Market Research Future | 英文 152 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計連續血糖監測系統市場規模將從2023年的88億美元和2024年的100億美元成長到2032年的258億美元，預測期內年複合成長率為 12.34%。

推動連續血糖監測系統市場擴張的顯著因素之一是全球糖尿病盛行率的上升。由於全世界受影響人數的顯著增加，糖尿病現已達到流行病的程度。The International Diabetes Federation（IDF）表示，2021年全球將有5.37億人患有糖尿病，預測到2030年這一數字將增加至6.43億。同樣，IDF 估計2021年有3,840萬美國人（佔總人口的11.6%）患有糖尿病。大約200萬美國人患有第1 型糖尿病，其中包括約 304,000名兒童和青少年。糖尿病發生率上升的原因包括人口老化、不良飲食習慣和不活躍的生活方式。隨著糖尿病人口的增加，對有效的糖尿病護理解決方案的需求也在增加。

區域洞察

北美市場所佔佔比最大。預計該市場將受到強大的技術基礎設施和完善的監管框架的推動。

由於糖尿病盛行率上升和 CGM 技術的發展，歐洲佔據第二大市場。

預計2023年至2032年，亞太地區將以驚人的速度成長。這是由於該地區糖尿病盛行率不斷上升以及糖尿病管理意識不斷增強的結果。

本報告調查了全球連續血糖監測系統市場，提供市場的定義和概述，市場成長的各種影響因素分析，市場規模推移和預測，各種區分、地區的細分，競爭環境，主要企業概況等彙整資料。

Global Continuous Glucose Monitoring Systems Market Research Report Information by Product (Sensors, And Transmitter and Receivers), By Application (Type 2, Type 1, Non-diabetic Patients), By End User (Hospitals & Clinics, Homecare Settings, And Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032

Market Outlook

USD 8.8 billion in continuous glucose monitoring systems market value in 2023 With a compound annual growth rate (CAGR) of 12.34% for the forecast period (2024 - 2032), the market for Continuous Glucose Monitoring Systems is expected to rise from USD 10.0 Billion in 2024 to USD 25.8 billion by 2032.

One very notable factor driving the expansion of the Continuous Glucose Monitoring Systems Market is the rising global diabetes prevalence. With an amazing global increase in affected individuals, diabetes now reaches pandemic proportions. The International Diabetes Federation (IDF) estimates that 537 million people globally will be living with diabetes in 2021 and that figure is predicted to rise to 643 million by 2030. Likewise, the American Diabetes Association estimates that in 2021 diabetes will afflict 38.4 million Americans, or 11.6% of the population. About 2.0 million Americans, including some 304,000 children and teenagers, have type 1 diabetes. Among the several causes of the rising diabetes incidence include aging population, poor eating habits, and inactive lifestyles. The need of efficient diabetes care solutions gets more urgent as the diabetic population keeps rising.

Insights about Market Segments

Based on product, the segmentation of the Continuous Glucose Monitoring Systems Market divides sensors and transmitter and receivers.

Application that comprises type 2 diabetes, type 1 diabetes, and non-diabetic patients forms the basis of the market segmentation.

End users ranging from hospitals and clinics to homecare environments and others form the basis of the market segmentation.

Regional Insights

The report groups the market by Region: North America, Europe, Asia-Pacific, and the Rest of the World. America North-West With a market share of the highest 2023 constant glucose monitoring systems The strong technological infrastructure is the reason behind this; so, it is envisaged that the market would be driven by a well-established regulatory framework.

Thanks to rising diabetes prevalence in Europe and developments in CGM technology, Europe Continuous Glucose Monitoring Systems market holds second-largest market share. Furthermore, the Rest of Europe Continuous Glucose Monitoring Systems market is predicted to fastest-growing market in the European area while France Continuous Glucose Monitoring Systems market was ascribed to hold the highest market share.

From 2023 to 2032, the Asia-Pacific Continuous Glucose Monitoring Systems market is predicted to expand at a noteworthy proportion. This is a result of growing diabetes prevalence in the area and growing consciousness of diabetes control. Furthermore projected to have the biggest market share is China Continuous Glucose Monitoring Systems market; India Market for Continuous Glucose Monitoring Systems is predicted to develop fastest among Asia-Pacific countries.

The Middle East and Africa plus Latin America comprise the Rest of the World. Rising diabetes prevalence along with growing awareness of advanced glucose monitoring systems would probably cause the market for Continuous Glucose Monitoring Systems in the above stated areas to rise.

Leading Players

Key Companies in the Continuous Glucose Monitoring Systems Market are Dexcom, Inc. (US), Menarini Diagnostics SRL (Italy), Sensonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc. (US), Ultrahuman Healthcare Pvt LTD (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), Sinocare (China).

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TECHNIQUE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING PREVALENCE OF DIABETES
- 4.2.2 RISING AWARENESS AMONG INDIVIDUALS ABOUT THE BENEFITS OF CONTINUOUS GLUCOSE MONITORING AND PATIENT EDUCATION
- 4.2.3 INCREASING GERIATRIC POPULATION
4.3 RESTRAINTS
- 4.3.1 HIGH COST OF CONTINUOUS GLUCOSE MONITORING SYSTEMS
4.4 OPPORTUNITY
- 4.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS AND INNOVATION

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION AND SALES
- 5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
- 5.3.1 OVERVIEW

6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

6.1 OVERVIEW
6.2 SENSORS
6.3 TRANSMITTER & RECEIVERS

7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 TYPE 2 DIABETES
7.3 TYPE 1 DIABETES
7.4 NON-DIABETIC PATIENTS
- 7.4.1 WEIGHT LOSS
- 7.4.2 DIET MANAGEMENT
- 7.4.3 HEALTH & WELLNESS

8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

8.1 OVERVIEW
8.2 HOSPITALS & CLINICS
8.3 HOMECARE SETTINGS
8.4 OTHERS

9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

9.1 GLOBAL
9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.2 CANADA
9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 FRANCE
- 9.3.3 UK
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 INDIA
- 9.4.3 JAPAN
- 9.4.4 SOUTH KOREA
- 9.4.5 AUSTRALIA
- 9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
- 9.5.1 MIDDLE EAST & AFRICA
- 9.5.2 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS,
10.3 COMPETITOR DASHBOARD
10.4 PUBLIC PLAYERS STOCK SUMMARY
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
- 10.6.2 AGREEMENT
- 10.6.3 PARTNERSHIP
- 10.6.4 COLLABORATION

11 COMPANY PROFILES

11.1 DEXCOM, INC
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 A. MENARINI DIAGNOSTICS SRL
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 KEY STRATEGIES
11.3 SENSEONICS
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 KEY STRATEGIES
11.4 MEDTRUM TECHNOLOGIES INC.
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 KEY STRATEGIES
11.5 NEMAURA MEDICAL INC.
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 SWOT ANALYSIS
- 11.5.6 KEY STRATEGIES
11.6 ULTRAHUMAN HEALTHCARE PVT LTD
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 KEY STRATEGIES
11.7 MEDTRONIC
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
11.8 ONE DROP
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 SWOT ANALYSIS
- 11.8.6 KEY STRATEGIES
11.9 ABBOTT LABORATORIES, INC.
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 SWOT ANALYSIS
- 11.9.6 KEY STRATEGIES
11.10 SINOCARE
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCTS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 KEY STRATEGIES
11.11 NUTRISENSE
- 11.11.1 COMPANY OVERVIEW
- 11.11.2 FINANCIAL OVERVIEW
- 11.11.3 PRODUCTS OFFERED
- 11.11.4 KEY DEVELOPMENTS
- 11.11.5 KEY STRATEGIES
11.12 SUPERSAPIENS
- 11.12.1 COMPANY OVERVIEW
- 11.12.2 FINANCIAL OVERVIEW
- 11.12.3 PRODUCTS OFFERED
- 11.12.4 KEY DEVELOPMENTS
- 11.12.5 KEY STRATEGIES
11.13 SIGNOS INC.
- 11.13.1 COMPANY OVERVIEW
- 11.13.2 FINANCIAL OVERVIEW
- 11.13.3 PRODUCTS OFFERED
- 11.13.4 KEY DEVELOPMENTS
- 11.13.5 KEY STRATEGIES
11.14 LEVELS
- 11.14.1 COMPANY OVERVIEW
- 11.14.2 FINANCIAL OVERVIEW
- 11.14.3 PRODUCTS OFFERED
- 11.14.4 KEY DEVELOPMENTS
- 11.14.5 KEY STRATEGIES
11.15 VERI
- 11.15.1 COMPANY OVERVIEW
- 11.15.2 FINANCIAL OVERVIEW
- 11.15.3 PRODUCTS OFFERED
- 11.15.4 KEY DEVELOPMENTS
- 11.15.5 KEY STRATEGIES
11.16 LUMEN
- 11.16.1 COMPANY OVERVIEW
- 11.16.2 FINANCIAL OVERVIEW
- 11.16.3 PRODUCTS OFFERED
- 11.16.4 KEY DEVELOPMENTS
- 11.16.5 KEY STRATEGIES
11.17 JANUARY.AI
- 11.17.1 COMPANY OVERVIEW
- 11.17.2 FINANCIAL OVERVIEW
- 11.17.3 PRODUCTS OFFERED
- 11.17.4 KEY DEVELOPMENTS
- 11.17.5 KEY STRATEGIES

12 DATA CITATIONS

簡介目錄圖表

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY REGION, 2019-2032 (USD MILLION)
TABLE 4 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTER & RECEIVERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 5 GLOBAL: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD MILLION)
TABLE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD MILLION)
TABLE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY REGION, 2019-2032 (USD MILLION)
TABLE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR WEIGHT LOSS, BY REGION, 2019-2032 (USD MILLION)
TABLE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR DIET MANAGEMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET HEALTH & WELLNESS, BY REGION, 2019-2032 (USD MILLION)
TABLE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION)
TABLE 15 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOMECARE SETTINGS, BY REGION, 2019-2032 (USD MILLION)
TABLE 16 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 17 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 18 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 19 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 20 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 21 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 22 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 23 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 24 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 25 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 26 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 27 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 28 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 29 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 30 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 31 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 32 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 33 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 34 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 35 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 36 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 37 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 38 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 39 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 40 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 41 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 42 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 43 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 44 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 45 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 46 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 47 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 48 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 49 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 50 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 51 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 52 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 53 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 54 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 55 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 56 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 57 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 58 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 59 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 60 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 61 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 62 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 63 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 64 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 65 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 66 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 67 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 68 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 69 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 70 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 71 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 72 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 73 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 74 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 75 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 76 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 77 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 78 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 79 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 80 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 81 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 82 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 83 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 84 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 85 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 86 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 87 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 88 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 89 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 90 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 91 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 92 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 93 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 94 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 95 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 96 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 97 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 98 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 99 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 100 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 101 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 102 PUBLIC PLAYERS STOCK SUMMARY
TABLE 103 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 104 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 105 AGREEMENT
TABLE 106 PERTNERSHIP
TABLE 107 COLLABORATION
TABLE 108 DEXCOM, INC: PRODUCT OFFERED
TABLE 109 DEXCOM, INC: KEY DEVELOPMENTS
TABLE 110 A. MENARINI DIAGNOSTICS SRL: PRODUCT OFFERED
TABLE 111 A. MENARINI DIAGNOSTICS SRL: KEY DEVELOPMENTS
TABLE 112 SENSEONICS: PRODUCT OFFERED
TABLE 113 SENSEONICS: KEY DEVELOPMENTS
TABLE 114 MEDTRUM TECHNOLOGIES INC.: PRODUCTS OFFERED
TABLE 115 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
TABLE 116 NEMAURA MEDICAL INC.: KEY DEVELOPMENTS
TABLE 117 ULTRAHUMAN HEALTHCARE PVT LTD.: PRODCUTS OFFERED
TABLE 118 MEDTRONIC: PRODUCTS OFFERED
TABLE 119 MEDTRONIC: KEY DEVELOPMENTS
TABLE 120 ONE DROP: PRODUCTS OFFERED
TABLE 121 ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 122 ABBOTT LABORATORIES, INC.: KEY DEVELOPMENTS
TABLE 123 SINOCARE: PRODUCTS OFFERED
TABLE 124 NUTRISENSE: PRODUCTS OFFERED
TABLE 125 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
TABLE 126 SIGNOS INC.: PRODUCTS OFFERED
TABLE 127 LEVELS: PRODUCTS OFFERED
TABLE 128 VERI: PRODUCTS OFFERED
TABLE 129 LUMEN: PRODUCTS OFFERED
TABLE 130 JANUARY.AI: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: STRUCTURE
FIGURE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
FIGURE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY PRODUCT,
FIGURE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY APPLICATION,
FIGURE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY END USER,
FIGURE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY REGION, 2023 (% SHARE)
FIGURE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 15 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 16 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 17 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 18 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 20 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY COUNTRY,
FIGURE 21 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 22 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY REGION,
FIGURE 23 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET PLAYERS: COMPETITIVE ANALSIS,
FIGURE 24 COMPETITOR DASHBOARD: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 25 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 DEXCOM, INC: SWOT ANALYSIS
FIGURE 27 SENSEONICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 NEMAURA MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 NEMAURA MEDICAL INC.: SWOT ANALYSIS
FIGURE 30 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 MEDTRONIC: SWOT ANALYSIS
FIGURE 32 ONE DROP: SWOT ANALYSIS
FIGURE 33 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ABBOTT LABORATORIES INC.: SWOT ANALYSIS LIST OF FIGURES
FIGURE 1 GLOBAL DIGITAL HEALTH MARKET: STRUCTURE
FIGURE 2 GLOBAL DIGITAL HEALTH MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2032)
FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL DIGITAL HEALTH MARKET
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DIGITAL HEALTH MARKET
FIGURE 7 GLOBAL DIGITAL HEALTH MARKET, BY TECHNOLOGY, SEGMENT ATTRACTIVENESS, 2024-2032 (USD MILLION)
FIGURE 8 GLOBAL DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION)
FIGURE 9 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY TECHNOLOGY,
FIGURE 10 GLOBAL DIGITAL HEALTH MARKET, BY COMPONENT, SEGMENT ATTRACTIVENESS, 2024-2032 (USD MILLION)
FIGURE 11 GLOBAL DIGITAL HEALTH MARKET, BY COMPONENT, 2023 & 2032 (USD MILLION)
FIGURE 12 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY COMPONENT,
FIGURE 13 GLOBAL DIGITAL HEALTH MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
FIGURE 14 GLOBAL DIGITAL HEALTH MARKET, END USER SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
FIGURE 15 GLOBAL DIGITAL HEALTH MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 16 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY END USER,
FIGURE 17 GLOBAL DIGITAL HEALTH MARKET SHARE, BY REGION, 2023 (% SHARE)
FIGURE 18 GLOBAL DIGITAL HEALTH MARKET, BY REGION, 2023 AND 2032 (USD MILLION)
FIGURE 19 NORTH AMERICA MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 20 NORTH AMERICA: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 21 NORTH AMERICA: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 & 20232 (USD MILLION)
FIGURE 22 EUROPE MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 23 EUROPE: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 24 EUROPE: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
FIGURE 25 ASIA-PAIFIC MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 26 ASIA-PAIFIC: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 27 ASIA-PAIFIC: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
FIGURE 28 REST OF THE WORLD MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 29 REST OF THE WORLD: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 30 REST OF THE WORLD: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
FIGURE 31 GLOBAL DIGITAL HEALTH MARKET PLAYERS: COMPETITIVE ANALSIS,
FIGURE 32 COMPETITOR DASHBOARD: GLOBAL DIGITAL HEALTH MARKET
FIGURE 33 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ATHENAHEALTH: SWOT ANALYSIS
FIGURE 35 CISCO SYSTEMS, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 EPIC SYSTEMS CORPORATION: SWOT ANALYSIS
FIGURE 37 NXGN MANAGEMENT, LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 NXGN MANAGEMENT, LLC: SWOT ANALYSIS
FIGURE 39 MCKESSON CORPORATION: FINANCIAL OVERVIEW
FIGURE 40 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS
FIGURE 41 GENERAL ELECTRIC COMPANY: FINANCIAL OVERVIEW
FIGURE 42 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS
FIGURE 43 VERADIGM, LLC: FINANCIAL OVERVIEW SNAPSHOT